Concentrix Corporation
NASDAQ:CNXCInformation Technology Services
-$0.75 today
- Market cap
- $1.85B
- Beta
- 0.42
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$21.66
- Dividend yield
- 5.73%
Volume 0.65M
Average 1.64M
CNXC Operating Cash Flow
Cash generated by the company's core business operations during the period.
Concentrix CorporationNASDAQ: CNXC
Operating Cash Flow · Q1 FY2026 · quarter ended Feb 2026
Operating cash flow turns negative
Q1 FY2026 operating cash flow was -$83.22M, compared with $1.41M a year earlier. Trailing-twelve-month operating cash flow was $722.34M. Over 3 fiscal years it compounded at +10.3% a year.
Context
- Operating cash flow amounted to 8.2% of revenue in FY2025, up 1.3 pp from a year earlier.
- Operating cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly operating cash flow holds near -$83.22M or moves back toward the trailing-twelve-month quarterly average of $180.58M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 806.97M USD
- Year-over-year change
- +20.9%
- 4-year CAGR
- +11.9%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-11-30 | 806.97M | +20.9% |
| FY2024 | 2024-11-30 | 667.49M | -1.6% |
| FY2023 | 2023-11-30 | 678.01M | +12.9% |
| FY2022 | 2022-11-30 | 600.72M | +16.8% |
| FY2021 | 2021-11-30 | 514.18M | — |
Operating Cash Flow vs competitors
How CNXC compares with its peers on the latest reported figures
- CNXC's LTM Feb 2026 operating cash flow of $722.34M is the largest of the 9 companies compared; the peer median is $189.57M.
- Its year-over-year change of +0.9% is the 7th highest of 9, against a peer median of +15.5%.
- Operating cash flow amounts to 7.3% of revenue for CNXC, versus a peer median of 12.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Feb 2026 | $722.34M | +0.9% | +10.3% | 7.3% | |
| LTM Mar 2026 | $592M | -7.7% | +7.3% | 24.2% | |
| LTM Sep 2026 | $532.94M | +6.1% | +12.2% | 9.4% | |
| LTM Jun 2026 | $327.71M | -0.1% | +28.3% | 14.6% | |
| LTM Jun 2026 | $233.35M | +432.7% | — | 73.6% | |
| LTM Apr 2026 | $145.79M | +21.8% | +81.4% | 16.7% | |
| LTM Mar 2026 | $126.88M | +687.5% | -4.4% | 6.0% | |
| LTM Mar 2026 | $62.12M | +76.7% | +4.5% | 9.9% | |
| LTM Mar 2026 | $39.64M | +9.2% | +8.7% | 9.5% | |
| Peer median (excluding CNXC) | $189.57M | +15.5% | +8.7% | 12.3% | |
Competitors are the stored peer set for CNXC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Nov 2021 | FY2022 Nov 2022 | FY2023 Nov 2023 | FY2024 Nov 2024 | FY2025 Nov 2025 |
|---|---|---|---|---|---|
| Net Income | 405.58M | 435.64M | 313.84M | 251.22M | (1.28B) |
| Depreciation & Amortization | 277.18M | 309.54M | 388.3M | 705.85M | 660.43M |
| Deferred Income Tax | (25.73M) | (30.82M) | (121.71M) | (235.25M) | (154.88M) |
| Stock-Based Compensation | 36.18M | 47.14M | 62.11M | 96.06M | 96.39M |
| Change in Working Capital | (165.46M) | (165.02M) | (10.66M) | (166.89M) | (85.76M) |
| Accounts Receivables | (139.1M) | (53.13M) | (45.9M) | (63.85M) | (23.08M) |
| Inventory | (22.83M) | 0 | 0 | 0 | 0 |
| Accounts Payables | (4.55M) | 14.63M | 9.34M | (25.82M) | 28.47M |
| Other Working Capital | 1.02M | (126.51M) | 25.9M | (77.22M) | (91.16M) |
| Other Non-Cash Items | (13.56M) | 4.24M | 46.13M | 16.51M | 1.57B |
| Operating Cash Flow | 514.18M | 600.72M | 678.01M | 667.49M | 806.97M |
| Capital Expenditures | (149.08M) | (140.02M) | (180.53M) | (238.76M) | (234.5M) |
| Acquisitions (Net) | 70.43M | (1.7B) | (1.91B) | (5.5M) | (15.89M) |
| Purchases of Investments | 0 | (1M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 1M | 0 | 0 | 0 |
| Other Investing Activities | 0 | (1M) | (14.63M) | 0 | 0 |
| Investing Cash Flow | (78.65M) | (1.84B) | (2.11B) | (244.27M) | (250.38M) |
| Debt Repayment | (345M) | 1.43B | 1.98B | (208.69M) | (196.69M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 3.98M |
| Common Stock Repurchased | (57.49M) | (133.29M) | (81.19M) | (149.48M) | (188.71M) |
| Dividends Paid | (13.08M) | (53.43M) | (63.5M) | (83.81M) | (89.62M) |
| Other Financing Activities | 13.7M | (2.24M) | (36.63M) | (50.56M) | (20.4M) |
| Financing Cash Flow | (401.87M) | 1.24B | 1.8B | (492.53M) | (491.44M) |
| Effect of Forex Changes | (7M) | (24.52M) | (12.42M) | (17.58M) | 26.38M |
| Net Change in Cash | 26.66M | (25.55M) | 359.02M | (86.88M) | 91.52M |
| Free Cash Flow | 365.1M | 460.7M | 497.48M | 428.73M | 572.47M |
Concentrix Corporation
NASDAQ:CNXC
Intrinsic Alpha fair value
Locked
Current Price
$30.27
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.